recruitment

Pentasia has been recognised as Recruiter of the Year 2021 at the EGR B2B Awards held both in person and virtually over the past two days, which the company attributed to a sustained performance and commitment to supporting clients and candidates despite the tough economic climate of 2020.

Alastair Cleland
Alastair Cleland / Pentasia

Commenting on the recognition, Alastair Cleland, Managing Director at Pentasia, which is part of the Conexus Group, said “Pentasia is delighted to receive this award from EGR, a welcome acknowledgement of our commitment to continued recruitment excellence. Congratulations to all the other winners.” 

An international recruitment consultancy company specialised in iGaming, Pentasia supported clients to make a total of 415 high value placements in 2020. The firm also adapted its services to support clients to hire remotely and achieve their objectives despite travel restrictions.

“Nearly 100 per cent of our new business is referred by satisfied clients. Coming into 2021, demand is higher than ever; when iGaming businesses are looking to expand, they come to Pentasia first,” the firm said.

The annual EGR B2B Awards recognise the best service providers across all major egaming disciplines, including betting and gaming software, networks, mobile, payments, recruitment, IT and infrastructure.

Related

The Convenience Shop appoints Maria P. Deguara as Independent Non-Executive Director

17 October 2025
by Adel Montanaro

She will also serve as Chairperson of the Audit Committee.

Javier Moreno appointed to Director at MAPFRE Middlesea plc

17 October 2025
by Adel Montanaro

The appointment, first announced in April, has now received formal approval from the MFSA.

Maltese mothers speak out on balancing careers and parenthood

17 October 2025
by Nicole Zammit

A collective call for empathy and reform.

Roberta Metsola: Financial literacy ‘central to human dignity’

16 October 2025
by Nicole Zammit

People should 'understand how things work and have the ability to make informed decisions.'